GO:0016236 macroautophagy: Cellular Self-Digestion Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016236 macroautophagy is the autophagic process that proceeds via the formation of an autophagosome.
• Macroautophagy is a conserved lysosomal degradation pathway essential for cellular homeostasis and survival under stress.
• Dysfunctional macroautophagy is implicated in neurodegeneration, cancer, metabolic disorders, and aging.
• Key autophagy-related (ATG) genes, including ATG7, ATG5, and LC3, orchestrate autophagosome formation and cargo degradation.
• Macroautophagy is tightly regulated by nutrient-sensing pathways such as mTOR and AMPK, and by post-translational modifications like deacetylation.
• CRISPR-based knockout, knock-in, and overexpression models enable precise functional dissection of macroautophagy genes in disease contexts.
Description
Macroautophagy (GO:0016236) is a fundamental cellular catabolic process in which cytoplasmic components, including damaged organelles and protein aggregates, are sequestered into double-membrane vesicles called autophagosomes and delivered to lysosomes for degradation. This pathway is essential for maintaining cellular homeostasis, responding to nutrient stress, and defending against pathogens. The term macroautophagy is distinguished from other autophagic processes such as microautophagy and chaperone-mediated autophagy by its reliance on autophagosome formation. In the nervous system, macroautophagy supports neuronal survival and synaptic function, and its impairment contributes to neurodegenerative diseases. Beyond neurons, macroautophagy plays critical roles in quiescent and senescent cells, influencing longevity and tissue regeneration. Given its broad physiological importance, macroautophagy is a major research focus, with ongoing efforts to understand its molecular regulation and to develop therapeutic strategies targeting this pathway.
macroautophagy At A Glance
| GO ID | GO:0016236 |
|---|---|
| GO term | macroautophagy |
| Ontology | biological_process |
| Synonym | autophagy, selective autophagy |
| Major function | Lysosomal degradation of cytoplasmic components via autophagosome formation |
| Key regulators | ATG proteins, mTOR, AMPK, deacetylation enzymes |
| Associated diseases | Neurodegeneration, cancer, metabolic disorders, aging |
| Research methods | CRISPR screens, fluorescence imaging, proteomics, Ribo-seq |
What Is GO:0016236?
According to the Gene Ontology, macroautophagy (GO:0016236) is defined as the autophagic process that proceeds via the formation of an autophagosome. This definition encompasses the de novo formation of double-membrane autophagosomes, their expansion and closure, and subsequent fusion with lysosomes to degrade the enclosed cargo. The term is synonymous with autophagy and selective autophagy in common usage, although selective autophagy refers to specific cargo recognition.
Why Is macroautophagy Important in Cell Biology?
Macroautophagy is vital for cellular quality control and energy homeostasis, and its dysregulation is linked to a wide range of human pathologies, including neurodegeneration, cancer, and metabolic syndromes. Understanding the molecular mechanisms of macroautophagy is therefore critical for developing targeted therapies and for interpreting disease-associated genetic variants.
• Maintains cellular homeostasis by degrading damaged organelles and protein aggregates.
• Provides energy and nutrients during starvation through lysosomal recycling.
• Protects against neurodegeneration by clearing toxic protein aggregates in neurons.
• Plays dual roles in cancer, either suppressing tumorigenesis or promoting tumor survival depending on context.
• Regulates quiescent and senescent cell states, impacting tissue regeneration and aging.
• Is essential for synaptic function and plasticity in the central nervous system.
• Modulates immune responses and pathogen clearance.
• Influences cell cycle progression and mitosis.
• Serves as a target for therapeutic intervention in metabolic and neurodegenerative diseases.
• Enables high-throughput genetic screens to identify novel autophagy regulators.
What Happens During macroautophagy?
Initiation and Phagophore Formation
In simple terms: The cell starts building a double-membrane sac to engulf unwanted material.
Macroautophagy initiation begins with the formation of a phagophore, a cup-shaped double-membrane structure, which is nucleated by the ULK1 complex and the class III PI3K complex containing Beclin-1 (BECN1). This step is tightly regulated by nutrient status; under starvation, mTORC1 is inhibited, allowing ULK1 activation and phagophore formation. The ATG7-mediated conjugation of ATG12 to ATG5 and the lipidation of LC3 (ATG8) are essential for phagophore expansion. Deacetylation of ATG7 by SIRT1 or other deacetylases promotes its activity and induces macroautophagy.
Autophagosome Elongation and Closure
In simple terms: The sac grows and seals to become a complete autophagosome.
The phagophore elongates through the addition of lipids and ATG proteins, particularly the ATG12-ATG5-ATG16L1 complex and LC3-phosphatidylethanolamine (LC3-II). LC3-II remains associated with the autophagosomal membrane and is widely used as a marker for autophagosome formation. Closure of the autophagosome results in a double-membrane vesicle containing cytoplasmic cargo. This process is influenced by various signaling pathways, including those involving AMPK and mTOR.
Fusion with Lysosomes and Degradation
In simple terms: The sealed sac fuses with a lysosome, where enzymes break down the contents.
Mature autophagosomes fuse with lysosomes to form autolysosomes, where lysosomal hydrolases degrade the inner autophagosomal membrane and cargo. This fusion step is mediated by SNARE proteins, Rab GTPases, and the HOPS complex. Degradation products, such as amino acids and lipids, are recycled back to the cytoplasm to support metabolism. Defects in autophagosome-lysosome fusion lead to accumulation of autophagosomes and are associated with diseases like neurodegeneration.
Selective Cargo Recognition
In simple terms: The cell can tag specific items for destruction by autophagy.
Selective macroautophagy involves cargo receptors such as p62/SQSTM1, NBR1, and OPTN, which recognize ubiquitinated substrates and link them to LC3 on the autophagosome. This allows targeted degradation of protein aggregates, damaged mitochondria (mitophagy), and intracellular pathogens (xenophagy). Selective autophagy is critical for neuronal health, as impaired clearance of aggregated proteins contributes to neurodegeneration.
Regulation by Cellular States
In simple terms: Autophagy activity changes depending on whether cells are growing, dividing, or resting.
Macroautophagy is repressed during mitosis, ensuring that cell division proceeds without interference from degradation processes. In quiescent and senescent cells, macroautophagy is essential for survival and longevity, but excessive autophagy can cause lysosomal damage and limit re-entry into the cell cycle. These context-dependent roles highlight the need for precise experimental models to study macroautophagy in different cellular states.
Key Genes Involved in GO:0016236 macroautophagy
The following genes and proteins are core components and regulators of macroautophagy, as established in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG7 | E1-like enzyme activating ATG12 and LC3 conjugation | Central to autophagosome formation; deacetylation regulates its activity |
| ATG5 | Conjugates with ATG12 to form E3-like complex | Essential for LC3 lipidation and autophagosome elongation |
| ATG12 | Ubiquitin-like protein conjugated to ATG5 | Required for phagophore expansion |
| LC3B (MAP1LC3B) | Ubiquitin-like protein lipidated to autophagosomal membrane | Marker of autophagosomes; used in imaging and flux assays |
| BECN1 | Component of PI3K complex for phagophore nucleation | Regulates initiation; often dysregulated in cancer |
| ULK1 | Serine/threonine kinase initiating autophagy | Target of mTORC1; key node in nutrient sensing |
| SQSTM1 (p62) | Selective autophagy receptor | Links ubiquitinated cargo to LC3; marker of autophagic flux |
| NBR1 | Selective autophagy receptor | Recognizes ubiquitinated proteins for degradation |
| OPTN | Autophagy receptor involved in mitophagy and xenophagy | Mutations linked to neurodegenerative diseases |
| ATG16L1 | Part of ATG12-ATG5-ATG16L1 complex | Required for LC3 lipidation; associated with Crohn's disease |
| ATG9A | Transmembrane protein involved in phagophore nucleation | Essential for autophagosome formation |
| VPS34 (PIK3C3) | Class III PI3K generating PI3P for autophagosome nucleation | Regulates initiation; target for inhibitors |
| RAB7A | GTPase mediating autophagosome-lysosome fusion | Late step of autophagy; defects impair degradation |
| SNARE proteins (e.g., STX17) | Mediate fusion of autophagosomes with lysosomes | Required for autolysosome formation |
| SIRT1 | Deacetylase that deacetylates ATG7 | Induces macroautophagy under stress |
| AMPK | Energy sensor kinase activating autophagy | Phosphorylates ULK1 and inhibits mTORC1 |
| mTOR | Nutrient-sensing kinase inhibiting autophagy | Central negative regulator; target of rapamycin |
| TFEB | Transcription factor activating autophagy and lysosomal genes | Master regulator of autophagic-lysosomal biogenesis |
How Is macroautophagy Regulated?
Macroautophagy is regulated at multiple levels. The mTORC1 pathway is the primary negative regulator; under nutrient-rich conditions, mTORC1 phosphorylates ULK1 and ATG13, suppressing autophagy initiation. Conversely, AMPK activates autophagy by phosphorylating ULK1 and inhibiting mTORC1 during energy stress. Post-translational modifications, such as deacetylation of ATG7 by SIRT1, directly enhance ATG7 activity and induce macroautophagy. Additionally, transcription factors like TFEB and FOXO3 promote the expression of autophagy-related genes. Cellular states such as mitosis and quiescence also modulate autophagy; for example, macroautophagy is repressed during mitosis, while in quiescent cells, it supports survival but can cause lysosomal damage upon re-entry.
macroautophagy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATG7 | Neurodegeneration, cancer | Conditional knockout mouse, neuronal cell lines |
| BECN1 | Cancer predisposition | Knockout and overexpression cell models |
| SQSTM1 (p62) | Pagets disease, ALS | Point mutation knock-in mice |
| OPTN | Glaucoma, ALS | Knockout and knock-in models |
| ATG16L1 | Crohns disease | Knock-in mice, intestinal organoids |
Macroautophagy in Neurodegeneration
Impaired macroautophagy contributes to the accumulation of toxic protein aggregates in neurons, a hallmark of neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis. In the CNS, macroautophagy is essential for synaptic function and neuronal survival, and its dysfunction leads to synaptic failure and neurodegeneration. For instance, impaired neuronal macroautophagy in the prelimbic cortex is associated with anxiety-like behaviors in chronic neuropathic pain models. Enhancing macroautophagy is therefore considered a therapeutic strategy for these conditions.
Macroautophagy in Cancer
Macroautophagy plays context-dependent roles in cancer. In early tumorigenesis, it suppresses cancer by clearing damaged organelles and reducing oxidative stress; however, in established tumors, it can promote survival under metabolic stress and contribute to chemoresistance. Mutations in autophagy genes such as BECN1 and ATG7 have been linked to cancer predisposition. Targeting macroautophagy is an active area of cancer therapy research.
Macroautophagy in Aging and Metabolic Disorders
Macroautophagy declines with age, and its dysfunction is implicated in aging and age-related metabolic disorders. In quiescent and senescent cells, macroautophagy supports longevity but can also induce lysosomal damage that limits cell re-entry and tissue regeneration. Modulating macroautophagy may therefore influence lifespan and metabolic health.
Macroautophagy in Pain and Anxiety
Recent studies have linked impaired macroautophagy in specific brain regions to comorbid anxiety-like behaviors in chronic pain. This suggests that targeting macroautophagy could alleviate affective symptoms associated with chronic pain.
From macroautophagy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATG7 impair autophagic flux? | ATG7 knockout cell lines and conditional knockout mice |
| How do disease-associated mutations in SQSTM1 affect cargo recognition? | Point mutation knock-in cell lines |
| Can overexpression of TFEB enhance clearance of protein aggregates? | TFEB overexpression cell models and transgenic mice |
| What is the role of ATG16L1 in intestinal homeostasis? | ATG16L1 knock-in mice and organoids |
| How does deacetylation of ATG7 regulate autophagy induction? | ATG7 acetylation-site point mutants |
| Does selective autophagy receptor OPTN protect against neurodegeneration? | OPTN knockout and knock-in neurons |
How to Study the macroautophagy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GFP-LC3 imaging | Autophagosome number and localization | Monitoring autophagy induction in cells |
| mCherry-GFP-LC3 flux assay | Autophagic flux (autophagosome to autolysosome) | Assessing degradation capacity |
| CRISPR knockout screens | Genes required for autophagy | Discovery of novel regulators |
| Proteomics | Protein abundance and modifications | Identifying autophagy substrates and regulators |
| Ribo-seq | Translational efficiency of autophagy genes | Studying translational control |
| Western blot for LC3-II | LC3 lipidation levels | Standard autophagy marker |
| Electron microscopy | Ultrastructure of autophagosomes | Confirming double-membrane vesicles |
| Immunofluorescence for p62 | Selective autophagy cargo clearance | Evaluating autophagic degradation |
Fluorescence Imaging and Autophagic Flux Assays
Fluorescence microscopy using GFP-LC3 or mCherry-GFP-LC3 reporters allows visualization of autophagosome formation and flux. Tandem reporters distinguish autophagosomes from autolysosomes based on pH sensitivity. These methods are widely used to assess macroautophagy activity in live cells and tissues.
CRISPR Screens for Autophagy Regulators
Genome-wide CRISPR knockout screens have identified novel genes required for macroautophagy under basal and stress conditions. Such screens use reporters of autophagic flux or survival under starvation to enrich for autophagy-deficient cells. The resulting candidate genes can be validated by targeted knockout and imaging.
Proteomics and Ribo-seq
Mass spectrometry-based proteomics can quantify changes in autophagosome-associated proteins and degradation products. Ribo-seq measures translation of autophagy-related genes, revealing translational control during autophagy induction. These approaches provide systems-level insights into macroautophagy regulation.
Genetic Knockout and Knock-in Models
CRISPR-Cas9-mediated knockout of ATG genes in cell lines and mice is a standard approach to study loss of macroautophagy. Knock-in of point mutations or tags (e.g., GFP-LC3) enables tracking of endogenous proteins and disease variants. These models are essential for linking specific genes to macroautophagy functions in vivo.
How CRISPR Can Be Used to Study GO:0016236 macroautophagy
Knockout
CRISPR knockout of core ATG genes such as ATG7, ATG5, or BECN1 completely abolishes macroautophagy, providing a clean background to study its cellular functions. These knockout models are used to validate candidate genes from screens and to assess the contribution of macroautophagy to disease phenotypes.
Point Mutation
Introducing disease-associated point mutations (e.g., in SQSTM1 or OPTN) via CRISPR knock-in allows precise modeling of how these variants affect selective autophagy and cargo recognition. Such models are crucial for understanding the molecular basis of autophagy-related diseases.
Knock-in
Knock-in of fluorescent tags (e.g., GFP-LC3) or epitope tags (e.g., HA-ATG7) enables real-time tracking and biochemical analysis of endogenous proteins. Tagged knock-in models avoid overexpression artifacts and provide physiological expression levels.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of autophagy regulators like TFEB or ATG7 can enhance macroautophagy and is used to test whether boosting autophagy alleviates disease phenotypes. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports macroautophagy Research
Researchers studying macroautophagy-related genes often need to determine whether a candidate gene is causally involved in autophagosome formation, cargo recognition, or lysosomal degradation. Precise genetic models are essential to dissect these mechanisms and to validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for macroautophagy research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TCIRG1 Overexpression THP-1 Stable Cell Line | EDC90140 | Human | 10312 | Details Get a Quote |
| UBQLN1 Knockout HEK293 Cell Line | EDJ-KQ194 | Human | 29979 | Details Get a Quote |
| SQSTM1 Knockout HEK293 Cell Line | EDC08337 | Human | 8878 | Details Get a Quote |
| STAM Knockout HEK293 Cell Line | EDJ-KQ533 | Human | 8027 | Details Get a Quote |
| STAM2 Knockout HEK293 Cell Line | EDJ-KQ534 | Human | 10254 | Details Get a Quote |
| PGAM5 Knockout HEK293 Cell Line | EDJ-KQ883 | Human | 192111 | Details Get a Quote |
| MTMR14 Knockout HEK293 Cell Line | EDJ-KQ988 | Human | 64419 | Details Get a Quote |
| BECN1 Knockout HEK293 Cell Line | EDJ-KQ1024 | Human | 8678 | Details Get a Quote |
| ATG16L1 Knockout HEK293 Cell Line | EDJ-KQ1068 | Human | 55054 | Details Get a Quote |
| ULK1 Knockout HEK293 Cell Line | EDJ-KQ1175 | Human | 8408 | Details Get a Quote |
| MAP1LC3C Knockout HEK293 Cell Line | EDJ-KQ1444 | Human | 440738 | Details Get a Quote |
| MAP1LC3A Knockout HEK293 Cell Line | EDJ-KQ1445 | Human | 84557 | Details Get a Quote |
| ATG12 Knockout HEK293 Cell Line | EDJ-KQ1541 | Human | 9140 | Details Get a Quote |
| MTMR3 Knockout HEK293 Cell Line | EDJ-KQ1665 | Human | 8897 | Details Get a Quote |
| RAB2A Knockout HEK293 Cell Line | EDJ-KQ1880 | Human | 5862 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »
Frequently Asked Questions About macroautophagy
What is macroautophagy?
Macroautophagy is a cellular degradation process where cytoplasmic components are engulfed in autophagosomes and delivered to lysosomes for breakdown.
What genes are involved in macroautophagy?
Key genes include ATG7, ATG5, ATG12, LC3B, BECN1, ULK1, SQSTM1, and many others that regulate autophagosome formation and cargo recognition.
What is the difference between macroautophagy and microautophagy?
Macroautophagy involves autophagosome formation, while microautophagy directly engulfs cargo at the lysosomal membrane.
How is macroautophagy regulated?
It is regulated by nutrient-sensing pathways like mTOR and AMPK, and by post-translational modifications such as deacetylation of ATG7.
What diseases are associated with defective macroautophagy?
Neurodegenerative diseases, cancer, metabolic disorders, and aging-related conditions are linked to macroautophagy dysfunction.
How can I study macroautophagy in the lab?
Common methods include GFP-LC3 imaging, autophagic flux assays, CRISPR screens, proteomics, and Ribo-seq.
What is the role of macroautophagy in neurons?
It supports neuronal survival and synaptic function, and its impairment contributes to neurodegeneration.
Can macroautophagy be induced pharmacologically?
Yes, rapamycin and other mTOR inhibitors induce macroautophagy, but their specificity and side effects require careful evaluation.
What is selective autophagy?
Selective autophagy is a type of macroautophagy where specific cargoes are recognized by receptors like p62 and targeted for degradation.
How does CRISPR help in macroautophagy research?
CRISPR enables knockout, knock-in, and overexpression of autophagy genes to dissect their functions and model diseases.
Conclusion
Macroautophagy (GO:0016236) is a central cellular pathway for maintaining homeostasis through lysosomal degradation of cytoplasmic components. Its dysregulation is implicated in numerous diseases, making it a critical area of biomedical research. Advances in CRISPR-based models and high-throughput screening continue to uncover new regulators and therapeutic opportunities.
References
- 1. Yamamoto H et al.. 2024. Molecular Mechanisms of Macroautophagy, Microautophagy, and Chaperone-Mediated Autophagy.. J Nippon Med Sch 91(1):2-9 PMID: 37271546
- 2. Griffey CJ et al.. 2022. Macroautophagy in CNS health and disease.. Nat Rev Neurosci 23(7):411-427 PMID: 35505254
- 3. Wosnitzka E et al.. 2025. Macroautophagy at the service of synapses.. Curr Opin Neurobiol 93:103054 PMID: 40414166
- 4. Murley A et al.. 2025. Quiescent cell re-entry is limited by macroautophagy-induced lysosomal damage.. Cell 188(10):2670-2686.e14 PMID: 40203825
- 5. Murley A et al.. 2023. Macroautophagy in quiescent and senescent cells: a pathway to longevity?. Trends Cell Biol 33(6):495-504 PMID: 36414491
- 6. Xu Y et al.. 2024. Deacetylation of ATG7 drives the induction of macroautophagy and LC3-associated microautophagy.. Autophagy 20(5):1134-1146 PMID: 37999993
- 7. Fu S et al.. 2024. Impaired neuronal macroautophagy in the prelimbic cortex contributes to comorbid anxiety-like behaviors in rats with chronic neuropathic pain.. Autophagy 20(7):1559-1576 PMID: 38522078
- 8. Odle RI et al.. 2020. Macroautophagy is repressed during mitosis - seeing is believing.. Autophagy 16(4):775-776 PMID: 32079445
